Appen share price tipped to hit $28.00 in 2019

The Appen Ltd (ASX:APX) share price has been tipped to climb to $28.00 by one leading broker in 2019. Should you invest?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Appen Ltd (ASX: APX) share price returned from its trading halt on Tuesday and tumbled 9% lower to $22.14.

Despite this decline the shares of the global leader in the development of high-quality, human annotated datasets for machine learning and artificial intelligence are still up 72.5% since the start of the year.

This makes Appen the best performer on the ASX 200 in 2019 ahead of payments company Afterpay Touch Group Ltd (ASX: APT) and iron ore producer Fortescue Metals Group Limited (ASX: FMG).

Is it too late to buy Appen shares?

I don't believe it is too late to invest in Appen, especially if you're prepared to make a buy and hold investment.

I'm not alone with this view. According to a note out of Citi on Tuesday, the broker has upgraded Appen's shares to a buy rating from neutral and lifted the price target on them by 20% to $28.04 following the acquisition of the Figure Eight business.

This price target implies potential upside of almost 27% for its shares over the next 12 months.

Figure Eight is a best in class machine learning software platform which uses highly automated annotation tools to transform unstructured text, image, audio and video data into customised high-quality artificial intelligence training data.

Citi believes that Figure Eight is a good fit for Appen and expects it to provide the technology and expertise required to allow the company to scale and improve its productivity materially.

However, as the Figure Eight business made a loss in FY 2018, the broker expects it to act as a drag on Appen's performance this year. As a result, it has lowered its earnings estimates slightly for FY 2019.

After which, it believes the business will contribute strongly to Appen's FY 2020 and FY 2021 results.

I think Citi makes a great point on Appen and believe it is a quality investment option. Its shares are trading at a premium to the market average, though. Whilst I believe its strong growth potential justifies this, they are still a reasonably high risk option and could be unsuitable for investors with a low tolerance for risk. It is also worth noting that Citi handled the capital raising to fund the acquisition of Figure Eight.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO and Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Man pointing at a blue rising share price graph.
Growth Shares

The 3 biggest ASX multibaggers in 2025

These billion-dollar ASX companies have delivered eye-catching multibagger returns in 2025.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These world class ASX 200 growth shares could rise 40% to 80%

These high-quality shares are seriously undervalued according to brokers.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

3 ASX mid-cap rockets that could become future blue chips

These stocks could be destined for big things in the future according to analysts.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

A man has a surprised and relieved expression on his face.
Growth Shares

These exciting ASX 200 growth shares could rise 60% to 100% in 2026

Analysts believe these shares could be dirt cheap and strong buys right now.

Read more »

Military soldier standing with army land vehicle as helicopters fly overhead.
Growth Shares

After falling 50%, this under-the-radar growth stock looks like brilliant value to me

A big pullback and rising momentum make EOS one to watch.

Read more »